I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for our fiscal '25 third-quarter video earnings webcast. Before we go inside to ...

The image is fabricated, the Pennsylvania Department of Health confirmed. The supposed document originated from a satirical account.

The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for ...